Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Streptococcus tigurinus is frequent among gtfR-negative Streptococcus oralis isolates and in the human oral cavity, but highly virulent strains are uncommon.

Conrads G, Barth S, Möckel M, Lenz L, van der Linden M, Henne K.

J Oral Microbiol. 2017 Apr 20;9(1):1307079. doi: 10.1080/20002297.2017.1307079. eCollection 2017.

2.

Group B Streptococcus vaccine: state of the art.

Nuccitelli A, Rinaudo CD, Maione D.

Ther Adv Vaccines. 2015 May;3(3):76-90. doi: 10.1177/2051013615579869. Review.

3.

Sequence variability is correlated with weak immunogenicity in Streptococcus pyogenes M protein.

Lannergård J, Kristensen BM, Gustafsson MC, Persson JJ, Norrby-Teglund A, Stålhammar-Carlemalm M, Lindahl G.

Microbiologyopen. 2015 Oct;4(5):774-89. doi: 10.1002/mbo3.278. Epub 2015 Jul 15.

4.

Identification of a Conserved Linear B-Cell Epitope of Streptococcus dysgalactiae GapC Protein by Screening Phage-Displayed Random Peptide Library.

Zhang L, Zhang H, Fan Z, Zhou X, Yu L, Sun H, Wu Z, Yu Y, Song B, Ma J, Tong C, Wang X, Zhu Z, Cui Y.

PLoS One. 2015 Jun 29;10(6):e0131221. doi: 10.1371/journal.pone.0131221. eCollection 2015.

5.

Survey of immunological features of the alpha-like proteins of Streptococcus agalactiae.

Maeland JA, Afset JE, Lyng RV, Radtke A.

Clin Vaccine Immunol. 2015 Feb;22(2):153-9. doi: 10.1128/CVI.00643-14. Epub 2014 Dec 24. Review.

6.

Affinity purification of human factor H on polypeptides derived from streptococcal m protein: enrichment of the Y402 variant.

Nilsson OR, Lannergård J, Morgan BP, Lindahl G, Gustafsson MC.

PLoS One. 2013 Nov 21;8(11):e81303. doi: 10.1371/journal.pone.0081303. eCollection 2013.

7.

Factor H binds to the hypervariable region of many Streptococcus pyogenes M proteins but does not promote phagocytosis resistance or acute virulence.

Gustafsson MC, Lannergård J, Nilsson OR, Kristensen BM, Olsen JE, Harris CL, Ufret-Vincenty RL, Stålhammar-Carlemalm M, Lindahl G.

PLoS Pathog. 2013;9(4):e1003323. doi: 10.1371/journal.ppat.1003323. Epub 2013 Apr 18.

8.

Role of pilus proteins in adherence and invasion of Streptococcus agalactiae to the lung and cervical epithelial cells.

Sharma P, Lata H, Arya DK, Kashyap AK, Kumar H, Dua M, Ali A, Johri AK.

J Biol Chem. 2013 Feb 8;288(6):4023-34. doi: 10.1074/jbc.M112.425728. Epub 2012 Dec 3.

9.

CsrRS and environmental pH regulate group B streptococcus adherence to human epithelial cells and extracellular matrix.

Park SE, Jiang S, Wessels MR.

Infect Immun. 2012 Nov;80(11):3975-84. doi: 10.1128/IAI.00699-12. Epub 2012 Sep 4.

10.

Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein.

Nordström T, Movert E, Olin AI, Ali SR, Nizet V, Varki A, Areschoug T.

J Biol Chem. 2011 Sep 30;286(39):33981-91. doi: 10.1074/jbc.M111.251728. Epub 2011 Jul 27.

11.

Structural vaccinology to thwart antigenic variation in microbial pathogens.

Schneewind O, Missiakas D.

Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10029-30. doi: 10.1073/pnas.1107324108. Epub 2011 Jun 13. No abstract available.

12.

Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes.

Kvam AI, Mavenyengwa RT, Radtke A, Maeland JA.

Clin Vaccine Immunol. 2011 Aug;18(8):1365-70. doi: 10.1128/CVI.05005-11. Epub 2011 Jun 8.

13.

Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.

Bronze MS, Dale JB.

Am J Med Sci. 2010 Sep;340(3):218-25. doi: 10.1097/MAJ.0b013e3181e939ab. Review.

14.

Correlation between Group B Streptococcal Genotypes, Their Antimicrobial Resistance Profiles, and Virulence Genes among Pregnant Women in Lebanon.

Hannoun A, Shehab M, Khairallah MT, Sabra A, Abi-Rached R, Bazi T, Yunis KA, Araj GF, Matar GM.

Int J Microbiol. 2009;2009:796512. doi: 10.1155/2009/796512. Epub 2010 Feb 2.

15.

Functional dissection of Streptococcus pyogenes M5 protein: the hypervariable region is essential for virulence.

Waldemarsson J, Stålhammar-Carlemalm M, Sandin C, Castellino FJ, Lindahl G.

PLoS One. 2009 Oct 1;4(10):e7279. doi: 10.1371/journal.pone.0007279.

16.

Streptococcus adherence and colonization.

Nobbs AH, Lamont RJ, Jenkinson HF.

Microbiol Mol Biol Rev. 2009 Sep;73(3):407-50, Table of Contents. doi: 10.1128/MMBR.00014-09. Review.

17.

Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5.

Carlin AF, Chang YC, Areschoug T, Lindahl G, Hurtado-Ziola N, King CC, Varki A, Nizet V.

J Exp Med. 2009 Aug 3;206(8):1691-9. doi: 10.1084/jem.20090691. Epub 2009 Jul 13.

18.

Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1.

Doro F, Liberatori S, Rodríguez-Ortega MJ, Rinaudo CD, Rosini R, Mora M, Scarselli M, Altindis E, D'Aurizio R, Stella M, Margarit I, Maione D, Telford JL, Norais N, Grandi G.

Mol Cell Proteomics. 2009 Jul;8(7):1728-37. doi: 10.1074/mcp.M800486-MCP200. Epub 2009 Apr 28.

19.

Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.

Yang HH, Mascuch SJ, Madoff LC, Paoletti LC.

Clin Vaccine Immunol. 2008 Jul;15(7):1035-41. doi: 10.1128/CVI.00030-08. Epub 2008 May 7.

Supplemental Content

Support Center